NCT07765992

Brief Summary

AI-Based Oxytocin-Stimulated Smart Lactation Support Vest: Development of a Thermo-Massage and Vibration Wearable Vest Design to Support Milk Flow and Prevent Milk Duct Obstruction During Lactation

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
17mo left

Started Dec 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 14, 2026

Completed
4 months until next milestone

Study Start

First participant enrolled

December 1, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

August 14, 2026

Status Verified

August 1, 2026

Enrollment Period

1 year

First QC Date

August 10, 2026

Last Update Submit

August 10, 2026

Conditions

Keywords

LactationBreast Milk ProductionWearable TechnologyThermo-MassageVibration TherapyArtificial IntelligenceSmart Wearable DeviceCesarean SectionNeonatal Intensive Care Unit

Outcome Measures

Primary Outcomes (1)

  • Daily Expressed Breast Milk Volume (mL/day)

    The amount of breast milk expressed by the mother per day, measured in milliliters (mL/day) during the 10-day follow-up period.

    Baseline (Day 0) through Day 10 postpartum

Secondary Outcomes (10)

  • Maternal Serum Oxytocin Level (pg/mL)

    Baseline, Day 5, and Day 10

  • Maternal Serum Prolactin Level (ng/mL)

    Baseline, Day 5, and Day 10

  • Maternal Serum Cortisol Level (µg/dL)

    Baseline, Day 5, and Day 10

  • Breast Fullness

    Day 1 through Day 10

  • Lactation Onset Symptoms

    Day 1 through Day 10

  • +5 more secondary outcomes

Study Arms (2)

Arm 1 - Intervention

EXPERIMENTAL

Participants assigned to the intervention group will use the AI-based oxytocin-stimulated smart lactation support vest for 10 days, three times daily, in addition to standard lactation care and counseling. Each session will consist of 5 minutes of heating, 15 minutes of heating combined with massage, and 10 minutes of heating combined with massage and vibration. The wearable system is designed to provide controlled thermo-massage and vibration stimulation to support milk flow and lactation during the early postpartum period.

Device: AI-Based Oxytocin-Stimulated Smart Lactation Support Vest

Arm 2 - Control

ACTIVE COMPARATOR

Participants assigned to the control group will receive standard lactation care and counseling according to the hospital protocol. Standard care will include routine lactation counseling, guidance regarding breastfeeding and milk expression, breast care, storage of expressed breast milk, daily reminders to express milk, and lactation support when clinically indicated.

Device: AI-Based Oxytocin-Stimulated Smart Lactation Support VestBehavioral: Standard Lactation Care and Counseling

Interventions

Participants assigned to the intervention group will use the AI-based oxytocin-stimulated smart lactation support vest for 10 days, three times daily, in addition to standard lactation care and counseling. Each session will consist of 5 minutes of heating, 15 minutes of heating combined with massage, and 10 minutes of heating combined with massage and vibration. The wearable vest is designed to provide controlled thermo-massage and vibration stimulation to support milk flow and lactation during the early postpartum period. The system includes temperature and bioelectrical impedance sensors and an AI-based decision-support module intended to provide individualized recommendations regarding stimulation parameters.

Arm 1 - InterventionArm 2 - Control

Participants assigned to the control group will receive standard lactation care and counseling according to the hospital protocol. Standard care will include routine lactation counseling, guidance regarding breastfeeding and milk expression, breast care, storage of expressed breast milk, daily reminders to express milk, and lactation support when clinically indicated.

Arm 2 - Control

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsIndividuals who self-identify as female and meet all other study eligibility criteria are eligible to participate.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • For Mothers:
  • Aged 18 years or older;
  • Primiparous;
  • Delivered by cesarean section;
  • Singleton pregnancy;
  • Delivered at 32-37 weeks of gestation;
  • Newborn admitted to the Neonatal Intensive Care Unit (NICU);
  • No medical condition that would prevent breast milk expression or use of the smart lactation support vest;
  • Owns or has access to a smartphone;
  • Willing to participate voluntarily and able to provide written informed consent;
  • Able to read, understand, and communicate in Turkish.
  • For Newborns:
  • Born at 32-37 weeks of gestation;
  • No condition that would prevent the intake of breast milk.

You may not qualify if:

  • For Mothers:
  • Body mass index (BMI) \>30 kg/m²;
  • History of a psychiatric diagnosis or currently receiving psychiatric treatment (e.g., depression, schizophrenia, obsessive-compulsive disorder);
  • Any medical condition that may interfere with breast milk expression (e.g., mastitis);
  • Stillbirth;
  • History of thyroid dysfunction;
  • Any physical condition or disability that prevents wearing the smart lactation support vest;
  • Previous breast surgery (e.g., breast implant surgery, mastectomy);
  • Insufficient Turkish language proficiency preventing the participant from understanding and completing the study instruments.
  • For Newborns:
  • Cleft palate or cleft lip;
  • Congenital anomaly;
  • Requirement for mechanical ventilation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Breast Feeding

Interventions

Counseling

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

Mental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Central Study Contacts

Seyhan Çankaya, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc.Prof.

Study Record Dates

First Submitted

August 10, 2026

First Posted

August 14, 2026

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

May 1, 2028

Last Updated

August 14, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant-level data (IPD) will not be shared with other researchers because the dataset contains potentially sensitive maternal and newborn health information. Data will be retained and managed by the research team in accordance with applicable ethical, institutional, and data protection requirements. De-identified aggregate findings will be reported in scientific publications and presentations.